OPRX OptimizeRx Corporation

OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, payers and providers, has been invited to participate in the Bank of America Merrill Lynch Health Care conference being held on May 12-14, 2020.

The event is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

OptimizeRx CEO William Febbo is scheduled to present on May 13, 2020, at 3:00 p.m. Eastern time, as well as participate in virtual one-on-one meetings. He will discuss a number of topics, including the company’s record Q1 results, client base that includes world’s Top 20 pharmaceutical companies, and how the company is supporting better health outcomes through its digital health network that now reaches reach 60% of the ambulatory market and patients nationwide.

He will also share insight on the company’s latest acquisition of a powerful digital therapeutics SaaS platform, RMDY Health, used by pharma, payers, medtech companies and medical associations worldwide.

The live presentation will be available at investors.optimizerx.com/events-and-presentations.

The event is for institutional clients of BOA and is by invitation only. To schedule a one-on-one meeting with OptimizeRx, please contact your BOA sales representative. For any questions about OptimizeRx, contact Ron Both of CMA at (949) 432-7557 or submit your request here.

About OptimizeRx®OptimizeRx Corporation (NASDAQ: OPRX) is a digital health company that facilitates communication at point-of-care among all stakeholders in healthcare. Primarily focused on life science and payer clients, its suite of digital and mobile SaaS-based solutions enables affordability, patient adherence and care management. OptimizeRx’s network reaches more than 60% of U.S. ambulatory providers, delivering therapeutic support on specialty medications and patient financial assistance directly within a provider’s workflow through leading electronic health platforms. OptimizeRx’s fully integrated platform supports the real-time exchange of information, improving provider knowledge and patient engagement, and ultimately leading to healthier outcomes.

For more information, go to OptimizeRx.com, and follow the company on Twitter and LinkedIn.

Important Cautions Regarding Forward Looking StatementsThis press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks.

OptimizeRx Contact Doug Baker, CFOTel (248) 651-6568 x807 dbaker@optimizerx.com

Media Relations Contact Maira Alejandra, Media Relations ManagerTel (754) 245-7070 malejandra@optimizerx.com

Investor Relations Contact Ron Both or Grant StudeCMA Investor RelationsTel (949) 432-7557 oprx@cma.team